CRISPR-Editing of the Vero Cell Line Improves Processability of Live Virus Vaccines by Enabling Targeted Proteolysis of Fibronectin.
Saved in:
| Title: | CRISPR-Editing of the Vero Cell Line Improves Processability of Live Virus Vaccines by Enabling Targeted Proteolysis of Fibronectin. |
|---|---|
| Authors: | Cahn JKB; Process Research & Development, Merck & Co. Inc., Rahway, New Jersey, USA., Ludwicki H; Process Research & Development, Merck & Co. Inc., West Point, Pennsylvania, USA., Shingler J; Process Research & Development, Merck & Co. Inc., West Point, Pennsylvania, USA., Gulvin S; Process Research & Development, Merck & Co. Inc., West Point, Pennsylvania, USA., Zhang Y; Analytical Research & Development, Merck & Co. Inc., West Point, Pennsylvania, USA., Kristopeit A; Process Research & Development, Merck & Co. Inc., West Point, Pennsylvania, USA., Ton C; Process Research & Development, Merck & Co. Inc., West Point, Pennsylvania, USA., Winters MA; Process Research & Development, Merck & Co. Inc., West Point, Pennsylvania, USA., Wagner JM; Process Research & Development, Merck & Co. Inc., West Point, Pennsylvania, USA., Moore J; Process Research & Development, Merck & Co. Inc., Rahway, New Jersey, USA. |
| Source: | Biotechnology and bioengineering [Biotechnol Bioeng] 2025 Aug; Vol. 122 (8), pp. 2082-2092. Date of Electronic Publication: 2025 May 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 7502021 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0290 (Electronic) Linking ISSN: 00063592 NLM ISO Abbreviation: Biotechnol Bioeng Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
